A detailed history of Vestor Capital, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Vestor Capital, LLC holds 13,502 shares of ABBV stock, worth $2.35 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
13,502
Previous 13,488 0.1%
Holding current value
$2.35 Million
Previous $2.31 Million 15.26%
% of portfolio
0.21%
Previous 0.19%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$163.84 - $199.33 $2,293 - $2,790
14 Added 0.1%
13,502 $2.67 Million
Q2 2024

Jul 30, 2024

SELL
$154.79 - $180.76 $57,272 - $66,881
-370 Reduced 2.67%
13,488 $2.31 Million
Q1 2024

May 14, 2024

SELL
$159.82 - $182.1 $4,474 - $5,098
-28 Reduced 0.2%
13,858 $2.52 Million
Q4 2023

Feb 07, 2024

BUY
$137.6 - $154.97 $58,480 - $65,862
425 Added 3.16%
13,886 $2.15 Million
Q3 2023

Nov 08, 2023

SELL
$133.59 - $154.65 $94,180 - $109,028
-705 Reduced 4.98%
13,461 $2.01 Million
Q2 2023

Aug 21, 2023

SELL
$132.51 - $164.9 $14 Million - $17.4 Million
-105,473 Reduced 88.16%
14,166 $1.91 Million
Q2 2023

Aug 09, 2023

BUY
$132.51 - $164.9 $11.8 Million - $14.7 Million
89,117 Added 291.98%
119,639 $34.3 Million
Q1 2023

May 10, 2023

SELL
$144.61 - $166.54 $84.1 Million - $96.8 Million
-581,261 Reduced 95.01%
30,522 $4.86 Million
Q1 2023

Apr 26, 2023

BUY
$144.61 - $166.54 $83.9 Million - $96.6 Million
580,104 Added 1831.19%
611,783 $30 Million
Q4 2022

Feb 13, 2023

SELL
$138.31 - $165.87 $139,969 - $167,860
-1,012 Reduced 3.1%
31,679 $5.12 Million
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $9.52 Million - $10.9 Million
-70,968 Reduced 68.46%
32,691 $4.39 Million
Q2 2022

Aug 10, 2022

BUY
$137.62 - $174.96 $5.59 Million - $7.1 Million
40,595 Added 64.37%
103,659 $15.9 Million
Q1 2022

May 09, 2022

BUY
$131.98 - $163.75 $6.62 Million - $8.22 Million
50,183 Added 389.59%
63,064 $10.2 Million
Q4 2021

Feb 11, 2022

SELL
$107.43 - $135.93 $44,690 - $56,546
-416 Reduced 3.13%
12,881 $1.74 Million
Q3 2021

Nov 15, 2021

BUY
$106.4 - $120.78 $113,209 - $128,509
1,064 Added 8.7%
13,297 $1.43 Million
Q4 2020

Feb 12, 2021

BUY
$80.49 - $108.67 $3,219 - $4,346
40 Added 0.33%
12,233 $1.31 Million
Q3 2020

Nov 13, 2020

SELL
$85.91 - $100.83 $30,669 - $35,996
-357 Reduced 2.84%
12,193 $1.07 Million
Q1 2020

May 14, 2020

SELL
$64.5 - $97.79 $408,994 - $620,086
-6,341 Reduced 33.57%
12,550 $956,000
Q4 2019

Feb 10, 2020

BUY
$72.13 - $90.25 $104,516 - $130,772
1,449 Added 8.31%
18,891 $1.67 Million
Q3 2019

Nov 20, 2019

BUY
$62.98 - $75.72 $84,078 - $101,086
1,335 Added 8.29%
17,442 $1.32 Million
Q2 2019

Aug 06, 2019

SELL
$65.7 - $83.98 $11,497 - $14,696
-175 Reduced 1.07%
16,107 $1.17 Million
Q1 2019

May 13, 2019

SELL
$77.14 - $90.79 $126,432 - $148,804
-1,639 Reduced 9.15%
16,282 $1.31 Million
Q1 2018

May 15, 2018

SELL
$92.01 - $123.21 $18,494 - $24,765
-201 Reduced 1.11%
17,921 $1.7 Million
Q4 2017

Feb 13, 2018

BUY
$89.56 - $98.21 $890,853 - $976,894
9,947 Added 121.68%
18,122 $1.75 Million
Q3 2017

Nov 08, 2017

BUY
$69.85 - $89.22 $571,023 - $729,373
8,175
8,175 $726,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $308B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Vestor Capital, LLC Portfolio

Follow Vestor Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vestor Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vestor Capital, LLC with notifications on news.